We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
-1.01%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$333M
AUM Growth
+$11.3M
Cap. Flow
+$20M
Cap. Flow %
6.01%
Top 10 Hldgs %
59.33%
Holding
178
New
81
Increased
27
Reduced
13
Closed
55

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$13.5M
2
PPG icon
PPG Industries
PPG
+$12.7M
3
UBS icon
UBS Group
UBS
+$11.1M
4
AXTA icon
Axalta
AXTA
+$10.5M
5
GRA
W.R. Grace & Co.
GRA
+$9.65M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$19.8M
2
TIMB icon
TIM SA
TIMB
+$16.8M
3
BIIB icon
Biogen
BIIB
+$11.8M
4
APD icon
Air Products & Chemicals
APD
+$9.94M
5
FTI icon
TechnipFMC
FTI
+$9.82M

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Materials 29.34%
3 Financials 10.86%
4 Technology 8.83%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$123B
$33M 9.9%
521,506
+138,180
+36% +$8.89M
ASH icon
2
Ashland
ASH
$3.1B
$30.8M 9.23%
440,623
+114,333
+35% +$8.23M
DD icon
3
DuPont de Nemours
DD
$18.3B
$22.6M 6.77%
139,835
+11,043
+9% +$2M
TMUS icon
4
T-Mobile US
TMUS
$212B
$22M 6.61%
361,120
+102,271
+40% +$6.4M
QGEN icon
5
Qiagen
QGEN
$8.35B
$21.1M 6.32%
614,152
-196,129
-24% -$6.89M
UBS icon
6
UBS Group
UBS
$169B
$16.4M 4.93%
932,519
+585,519
+169% +$11.1M
APD icon
7
Air Products & Chemicals
APD
$66.1B
$16.2M 4.86%
101,843
-60,300
-37% -$9.94M
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$12.6M 3.78%
+112,999
New +$13.5M
PPG icon
9
PPG Industries
PPG
$25.8B
$12.3M 3.69%
+110,269
New +$12.7M
NXPI icon
10
NXP Semiconductors
NXPI
$67.5B
$10.8M 3.24%
92,414
+40,305
+77% +$4.86M
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$11.4B
$10.8M 3.24%
133,067
-28,122
-17% -$2.41M
BIIB icon
12
Biogen
BIIB
$29.5B
$10.5M 3.15%
38,345
-38,051
-50% -$11.8M
AXTA icon
13
Axalta
AXTA
$6.87B
$10.1M 3.04%
+335,404
New +$10.5M
CTLT
14
DELISTED
CATALENT, INC.
CTLT
$9.58M 2.87%
233,199
+1,777
+0.8% +$75.6K
GRA
15
DELISTED
W.R. Grace & Co.
GRA
$8.62M 2.59%
+140,723
New +$9.65M
C icon
16
Citigroup
C
$216B
$8.48M 2.54%
125,578
+578
+0.5% +$43.4K
COL
17
DELISTED
Rockwell Collins
COL
$6.61M 1.98%
+49,000
New +$6.69M
MON
18
DELISTED
Monsanto Co
MON
$5.78M 1.73%
49,500
+16,200
+49% +$1.95M
CAVM
19
DELISTED
Cavium, Inc.
CAVM
$5.7M 1.71%
+71,857
New +$6.27M
BAC icon
20
Bank of America
BAC
$424B
$3.75M 1.12%
125,000
-125,000
-50% -$3.93M
HAWK
21
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$3.56M 1.07%
+79,565
New +$3.47M
OA
22
DELISTED
Orbital ATK, Inc.
OA
$3.45M 1.03%
+26,000
New +$3.43M
XL
23
DELISTED
XL Group Ltd.
XL
$3.32M 0.99%
60,000
+59,098
+6,552% +$2.59M
MSCC
24
DELISTED
Microsemi Corp
MSCC
$2.98M 0.89%
+46,000
New +$2.84M
NXTM
25
DELISTED
NxStage Medical Inc.
NXTM
$2.77M 0.83%
111,598
– –
1
2 3 4 5

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Exane Asset Management held 178 positions worth $333M, up 3.5% from $322M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Exane Asset Management deployed $20M of net new capital in Q1 2018, opening 81 new positions and adding to 27 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 112,999 shares worth $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 39% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $19.8M trimmed.

  • Exane Asset Management's largest Q1 2018 buy was Alexion Pharmaceuticals: 112,999 shares worth $12.6M.
  • Exane Asset Management added most to UBS Group in Q1 2018, an estimated $11.1M increase.
  • Exane Asset Management's biggest Q1 2018 reduction was Gilead Sciences, cutting an estimated $19.8M.
  • Exane Asset Management fully exited TIM SA in Q1 2018, selling an estimated $16.8M.
  • Exane Asset Management's ten largest holdings make up 59% of its $333M portfolio in Q1 2018.
  • Exane Asset Management opened 81 new positions and closed 55 in Q1 2018.
  • Exane Asset Management's portfolio value rose 3.5% quarter-over-quarter to $333M.

Based on Exane Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.